The treatment of minor depression with St. John's Wort or citalopram: Failure to show benefit over placebo

Journal of Psychiatric Research

Volumn 45, Issue 7, 2011, Pages 931-941

  Rapaport, Mark Hyman ^a,b   Nierenberg, Andrew A ^c   Howland, Robert ^d   Dording, Christina ^c   Schettler, Pamela J ^a   Mischoulon, David ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Minor depression; Pharmacotherapy treatment; St. John's Wort

Indexed keywords

CITALOPRAM; HYPERICUM PERFORATUM EXTRACT; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINOR DEPRESSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; STRUCTURED INTERVIEW; SWEATING; TREATMENT RESPONSE; WELLBEING;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY OF LIFE; YOUNG ADULT;

EID: 79958768945     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.05.001     Document Type: Article

References (50)

1. Alexopoulos G.S., Katz I.R., Reynolds C.F., Carpenter D., Docherty J.P. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgraduate Medicine 2001, 1-86. for the Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients, Special Report.
2. Allart-van Dam E., Hosman C.M., Hoogduin C.A., Schaap C.P. Prevention of depression in subclinically depressed adults: follow-up effects on the " Coping with Depression" course. Journal of Affective Disorders 2007, 97:219-228.
3. Diagnostic and statistical Manual of mental disorders 1994, American Psychiatric Association, (DSM-IV), American Psychiatric Association Press, Inc., Washington, D.C. 4th ed.
4. Diagnostic and statistical Manual of mental disorders 2000, American Psychiatric Association, Text Revision (DSM-IV-TR), American Psychiatric Association Press, Inc., Washington, D.C. 4th ed.
5. Barbui C., Cipriani A., Patel V., Ayuso-Mateos J.L., van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. British Journal of Psychiatry 2011, 198:11-16.
6. Broadhead W.E., Blazer D.G., George L.K., Tse C.K. Depression, disability days, and days lost work in a prospective epidemiologic survey. Journal of the American Medical Association 1990, 264:2524-2528.
7. Cohen J. Statistical power analysis for the behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale, New Jersey. 2nd ed.
8. Cuijpers P., Smit F., Voordouw I., Kramer J. Outcome of cognitive behaviour therapy for minor depression in routine practice. Psychology Psychotherapy Theory Research Practice 2005, 78:179-188.
9. Endicott J., Nee J., Harrison W., Blumenthal R. Quality of life enjoyment and satisfaction questionnaire (Q-LES-Q): a new measure. Psychopharmacology Bulletin 1993, 29:321-326.
10. First M.B., Spitzer R., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders, clinician version (SCID-CV) 1996, American Psychiatric Press, Inc., Washington, D.C.
11. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., et al. Antidepressant drug effects and severity of depression. Journal of the American Medical Association 2010, 303:47-53.
12. Guy W. ECDEU assessment Manual for Psychopharmacology, revised 1976, U.S. Government Printing Office, Washington, D.C.
13. Hamilton M. A rating scale for depression. Journal of NeurologyNeurosurgery and Psychiatry 1960, 12:56-62.
14. Howland R.H., Schettler P.J., Rapaport M.H., Mischoulon D., Schneider T., Fasiczka A., et al. Clinical features and functioning of patients with minor depression. Psychotherapy and Psychosomatics 2008, 77:384-389.
15. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. Journal of the American Medical Association 2002, 287:1807-1814. Hypericum Depression Trial Study Group.
16. Johnson J., Weissman M.M., Klerman G.L. Service utilization and social morbidity associated with depressive symptoms. Journal of the American Medical Association 1992, 267:1478-1483.
17. Judd L.L., Rapaport M.H., Yonkers K.A., Rush A.J., Frank E., Thase M.E., et al. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. American Journal of Psychiatry 2004, 161:1864-1871.
18. Kasper S., Gastpar M., Muller W.E., Volz H.P., Dienel A., Kieser M., et al. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:59-63.
19. Kessler R.C., Zhao S., Blazer D.G., Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. Journal of Affective Disorders 1997, 45:19-30.
20. Khan A., Leventhal R.M., Khan S.R., Brown W.A. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration Database. Journal of Clinical Psychopharmacology 2002, 22:40-45.
21. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PloS Medicine 2008, 5(2):e45.
22. Lecrubier Y., Clerc G., Didi R., Kieser M. Efficacy of St. John's Wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. American Journal of Psychiatry 2002, 159:1361-1366.
23. Linde K., Berner M.M., Kriston L. St. John's wort for major depression. Cochrane Database of Systematic Reviews 2008, (4). Article No. CD000448.
24. Maina G., Forner F., Bogetto F. Randomized controlled trial comparing brief dynamic and supportive therapy with waiting list condition in minor depressive disorders. Psychotherapy and Psychosomatics 2005, 74:43-50.
25. Moreno S.G., Sutton A.J., Turner E.H., Abrams K.R., Cooper N.J., Palmer T.M., et al. Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. British Medical Journal 2009, 339:b2981.
26. National Institute for Health and Clinical Excellence. CG90 depression in adults: NICE guidance (MS Word format). Issued October 2009 with March 2010 Update. Available on-line at: http://guidance.nice.org.uk/CG90/NICEGuidance/doc/English.
27. Nierenberg A.A., Rapaport M.H., Schettler P.J., Howland R.H., Smith J.A., Edwards D., et al. Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V. CNS Neuroscience and Therapeutics 2010, 16:208-216.
28. Parikh S.V., Segal Z.V., Griogoriadis S., Ravindran A.V., Kennedy S.H., Lam R.W., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. Journal of Affective Disorders 2009, S15-S25.
29. Rapaport M.H., Judd L.L., Schettler P.J., Yonkers K.A., Thase M.E., Kupfer D.J., et al. A descriptive analysis of minor depression. American Journal of Psychiatry 2002, 159:637-643.
30. Romanoski A.J., Folstein M.F., Nestadt G., Chahal R., Merchant A., Brown C.H., et al. The epidemiology of psychiatrist-ascertained depression and DSM-III depressive disorders. Results from the Eastern Baltimore mental health survey clinical Reappraisal. Psychological Medicine 1992, 22:629-655.
31. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B. Trivedi MH.The Inventory of depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 1996, 26:477-486.
32. Rush A.J., Carmody T.J., Reimitz P.E. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research 2000, 9:45-59.
33. Rush A.J., Fava M., Wisniewski S.R., Lavori P.W., Trivedi M.H., Sackeim H.A., et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Controlled Clinical Trials 2004, 25:119-142. Niederehe G for the STAR*D Investigators Group.
34. Ryff C.D. Happiness is everything, or is it? Explorations on the meaning of psychological well-being. Journal of Personality and Social Psychology 1989, 57:1069-1081.
35. Ryff C.D., Singer B. Psychological well-being: meaning, measurement, and implications for psychotherapy research. Psychotherapy and Psychosomatics 1996, 65:14-23.
36. Statistical analysis system (SAS), version 8.2 2001, SAS Institute Inc., SAS Institute, Cary, North Carolina.
37. Schechter D., Endicott J., Nee J. Quality of life of 'normal' controls: association with lifetime history of mental illness. Psychiatry Research 2007, 152:45-54.
38. Sewell W.H., Hauser R.M., Springer K.W., Hauser T.S. As we age: the Wisconsin Longitudinal study, 1957-2001. Research in social Stratification and Mobility 2002, JAI Press, Greenwich, Connecticut. K. Leicht (Ed.).
39. Shelton R.C., Keller M., Gelenberg A., Dunner D.L., Hirschfeld R., Thase M.E., et al. Effectiveness of St. John's wort in major depression: a randomized controlled trial. Journal of the American Medical Association 2001, 285:1978-1986.
40. Sherbourne C.D., Wells K.B., Hays R.D., Rogers W., Burnam M.A., Judd L.L. Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients. American Journal of Psychiatry 1994, 151:1777-1784.
41. Singer B.H. Best news yet on the six-factor model of well-being. Social Science Research 2006, 35:1103-1119.
42. Szigethy E., Kenney E., Carpenter J., Hardy D.M., Fairclough D., Bousvaros A., et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:1290-1298.
43. Trivedi M.H., Rush A.J., Ibrahim H.M., Carmody T.J., Biggs M.M., Suppes T., et al. The Inventory of depressive Symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the Quick Inventory of depressive Symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 2004, 34:73-82.
44. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 2008, 358:252-260.
45. Vitiello B., Shader R.I., Parker C.B., Ritz L., Harlan W., Greenblatt D.J., et al. Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. Journal of Clinical Psychopharmacology 2005, 25:243-249.
46. Volz H.P., Laux P. Potential treatment for subthreshold and mild depression: a comparison of St. John's Wort extracts and fluoxetine. Comprehensive Psychiatry 2000, 41(2 Suppl. 1):133-137.
47. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 health survey: manual and interpretation Guide 1993, New England Medical Center, Health Institute, Boston, Massachusetts.
48. Wells K.B., Stewart A., Hays R.D., Burnam M.A., Rogers W., Daniels M., et al. The functioning and well-being of depressed patients. Results from the medical outcomes study. Journal of the American Medical Association 1989, 262:914-919.
49. Williams J.W., Barrett J., Oxman T., Frank E., Katon W., Sullivan M., et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. Journal of the American Medical Association 2000, 284:1519-1526.
50. Zimmerman M., Posternak M.A., Chelminski I. Symptom severity and exclusion from antidepressant efficacy trials. Journal of Clinical Psychopharmacology 2002, 22:610-614.